Ke Xu1, Henry R Kranzler2, Richard Sherva3, Carolyn E Sartor1, Laura Almasy4, Ryan Koesterer3, Hongyu Zhao5, Lindsay A Farrer3, Joel Gelernter1,6. 1. Department of Psychiatry, Yale School of Medicine, and VA CT Healthcare Center, West Haven, Connecticut. 2. Department of Psychiatry, University of Pennsylvania Perelman School of Medicine and VISN 4 MIRECC, Philadelphia VA Medical Center, Philadelphia, Pennsylvania. 3. Department of Medicine (Biomedical Genetics), Boston University School of Medicine, Boston, Massachusetts. 4. Department of Psychiatry, Texas Biomedical Research Institute, San Antonio, Texas. 5. Department of Biostatistics, Yale School of Public Health, New Haven, Connecticut. 6. Department of Genetics and Neurobiology, Yale University School of Medicine, West Haven, Connecticut.
Abstract
BACKGROUND: We conducted a genomewide association study (GWAS) for maximum number of alcoholic drinks consumed in a 24-hour period ("MaxDrinks"), in 2 independent samples comprised of over 9,500 subjects, following up on our GWAS for alcohol dependence (AD) in European Americans (EAs) and African Americans (AAs). METHODS: The samples included our GWAS samples (Yale-UPenn) recruited for studies of the genetics of drug or AD, and a publicly available sample: the Study of Addiction: Genetics and Environment (SAGE). Genomewide association analysis was performed for ~890,000 single nucleotide polymorphisms (SNPs) using linear association random effects models. EAs and AAs were separately analyzed. RESULTS: The results confirmed significant associations of the well-known functional loci at ADH1B with MaxDrinks in EAs (rs1229984 Arg48His p = 5.96 × 10(-15) ) and AAs (rs2066702 Arg370Cys, p = 2.50 × 10(-10) ). The region of significant association on chromosome 4 was extended to LOC100507053 in AAs but not EAs. We also identified potentially novel significant common SNPs for MaxDrinks in EAs in the Yale-UPenn sample: rs1799876 at SERPINC1 on chromosome 1 (4.00 × 10(-8) ) and rs2309169 close to ANKRD36 on chromosome 2 (p = 5.58 × 10(-9) ). After adjusting for the peak SNP rs1229984 on ADH1B, rs1799876 was nearly significant (p = 1.99 × 10(-7) ) and rs2309169 remained highly significant (2.12 × 10(-9) ). CONCLUSIONS: The results provide further support that ADH1B modulates alcohol consumption. Future replications of potential novel loci are warranted. This is the largest MaxDrinks GWAS to date, the first in AAs.
BACKGROUND: We conducted a genomewide association study (GWAS) for maximum number of alcoholic drinks consumed in a 24-hour period ("MaxDrinks"), in 2 independent samples comprised of over 9,500 subjects, following up on our GWAS for alcohol dependence (AD) in European Americans (EAs) and African Americans (AAs). METHODS: The samples included our GWAS samples (Yale-UPenn) recruited for studies of the genetics of drug or AD, and a publicly available sample: the Study of Addiction: Genetics and Environment (SAGE). Genomewide association analysis was performed for ~890,000 single nucleotide polymorphisms (SNPs) using linear association random effects models. EAs and AAs were separately analyzed. RESULTS: The results confirmed significant associations of the well-known functional loci at ADH1B with MaxDrinks in EAs (rs1229984 Arg48His p = 5.96 × 10(-15) ) and AAs (rs2066702Arg370Cys, p = 2.50 × 10(-10) ). The region of significant association on chromosome 4 was extended to LOC100507053 in AAs but not EAs. We also identified potentially novel significant common SNPs for MaxDrinks in EAs in the Yale-UPenn sample: rs1799876 at SERPINC1 on chromosome 1 (4.00 × 10(-8) ) and rs2309169 close to ANKRD36 on chromosome 2 (p = 5.58 × 10(-9) ). After adjusting for the peak SNP rs1229984 on ADH1B, rs1799876 was nearly significant (p = 1.99 × 10(-7) ) and rs2309169 remained highly significant (2.12 × 10(-9) ). CONCLUSIONS: The results provide further support that ADH1B modulates alcohol consumption. Future replications of potential novel loci are warranted. This is the largest MaxDrinks GWAS to date, the first in AAs.
Authors: Laura J Bierut; Arpana Agrawal; Kathleen K Bucholz; Kimberly F Doheny; Cathy Laurie; Elizabeth Pugh; Sherri Fisher; Louis Fox; William Howells; Sarah Bertelsen; Anthony L Hinrichs; Laura Almasy; Naomi Breslau; Robert C Culverhouse; Danielle M Dick; Howard J Edenberg; Tatiana Foroud; Richard A Grucza; Dorothy Hatsukami; Victor Hesselbrock; Eric O Johnson; John Kramer; Robert F Krueger; Samuel Kuperman; Michael Lynskey; Karl Mann; Rosalind J Neuman; Markus M Nöthen; John I Nurnberger; Bernice Porjesz; Monika Ridinger; Nancy L Saccone; Scott F Saccone; Marc A Schuckit; Jay A Tischfield; Jen C Wang; Marcella Rietschel; Alison M Goate; John P Rice Journal: Proc Natl Acad Sci U S A Date: 2010-03-02 Impact factor: 11.205
Authors: Ellen E Quillen; Xiang-Ding Chen; Laura Almasy; Fang Yang; Hao He; Xi Li; Xu-Yi Wang; Tie-Qiao Liu; Wei Hao; Hong-Wen Deng; Henry R Kranzler; Joel Gelernter Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2013-11-26 Impact factor: 3.568
Authors: Ovidiu Dan Iancu; Alex M Colville; Beth Wilmot; Robert Searles; Priscila Darakjian; Christina Zheng; Shannon McWeeney; Sunita Kawane; John C Crabbe; Pamela Metten; Denesa Oberbeck; Robert Hitzemann Journal: Alcohol Clin Exp Res Date: 2018-06-22 Impact factor: 3.455
Authors: Joel Gelernter; Ning Sun; Renato Polimanti; Robert H Pietrzak; Daniel F Levey; Qiongshi Lu; Yiming Hu; Boyang Li; Krishnan Radhakrishnan; Mihaela Aslan; Kei-Hoi Cheung; Yuli Li; Nallakkandi Rajeevan; Fred Sayward; Kelly Harrington; Quan Chen; Kelly Cho; Jacqueline Honerlaw; Saiju Pyarajan; Todd Lencz; Rachel Quaden; Yunling Shi; Haley Hunter-Zinck; J Michael Gaziano; Henry R Kranzler; John Concato; Hongyu Zhao; Murray B Stein Journal: Biol Psychiatry Date: 2019-04-08 Impact factor: 13.382
Authors: Leslie A Brick; Matthew C Keller; Valerie S Knopik; John E McGeary; Rohan H C Palmer Journal: Addict Biol Date: 2017-11-27 Impact factor: 4.280